Astellas Pharma Inc. (ALPMF)

USD 10.12

(0.0%)

Operating Income Summary of Astellas Pharma Inc.

  • Astellas Pharma Inc.'s latest annual operating income in 2024 was 25.51 Billion JPY , down -80.82% from previous year.
  • Astellas Pharma Inc.'s latest quarterly operating income in 2024 FY was 178.07 Billion JPY , up 33.86% from previous quarter.
  • Astellas Pharma Inc. reported an annual operating income of 133.02 Billion JPY in 2023, down -14.55% from previous year.
  • Astellas Pharma Inc. reported an annual operating income of 155.68 Billion JPY in 2022, up 14.43% from previous year.
  • Astellas Pharma Inc. reported a quarterly operating income of 18.96 Billion JPY for 2024 Q3, up 263.07% from previous quarter.
  • Astellas Pharma Inc. reported a quarterly operating income of 37.72 Billion JPY for 2024 Q4, up 98.93% from previous quarter.

Annual Operating Income Chart of Astellas Pharma Inc. (2024 - 2004)

Historical Annual Operating Income of Astellas Pharma Inc. (2024 - 2004)

Year Operating Income Operating Income Growth
2024 25.51 Billion JPY -80.82%
2023 133.02 Billion JPY -14.55%
2022 155.68 Billion JPY 14.43%
2021 136.05 Billion JPY -44.24%
2020 243.99 Billion JPY 0.03%
2019 243.91 Billion JPY 14.37%
2018 213.25 Billion JPY -18.24%
2017 260.83 Billion JPY 4.76%
2016 248.98 Billion JPY 34.11%
2015 185.66 Billion JPY 58.95%
2014 116.8 Billion JPY -24.09%
2013 153.86 Billion JPY 16.99%
2012 131.51 Billion JPY 10.35%
2011 119.18 Billion JPY -36.06%
2010 186.4 Billion JPY -25.55%
2009 250.39 Billion JPY -9.25%
2008 275.9 Billion JPY 44.82%
2007 190.51 Billion JPY -1.3%
2006 193.02 Billion JPY 77.26%
2005 108.89 Billion JPY 7.85%
2004 100.96 Billion JPY 0.0%

Peer Operating Income Comparison of Astellas Pharma Inc.

Name Operating Income Operating Income Difference
AstraZeneca PLC 8.19 Billion USD -211.461%
Bristol-Myers Squibb Company PFD CONV 2 17.24 Billion USD -47.999%
CSPC Pharmaceutical Group Limited 7.01 Billion USD -263.711%
Clarus Therapeutics Holdings, Inc. -39.73 Million USD 64325.31%
Novartis AG 9.76 Billion USD -161.214%
PT Kalbe Farma Tbk. 3625.13 Billion USD 99.296%